Scopus
YÖKSİS DOI Eşleşti
SJR Q2
Evaluation of AI chatbots for patient education and information on chronic obstructive pulmonary disease
Heart and Lung · Ocak 2026
Özet
Background: Chronic obstructive pulmonary disease (COPD) is a chronic and progressive disease that affects patients' quality of life and functional capacity. With its widespread use and ease of access, AI chatbots stand out as an alternative source of patient-centered information and education. Objectives: To evaluate the readability and accuracy of information provided by ChatGPT, Gemini, and DeepSeek in COPD. Methods: Ten most frequently asked questions and answers regarding COPD in English were provided using three AI chatbots (ChatGPT-4 Turbo, Gemini 2.0 Flash, DeepSeek R1). Readability was assessed using the Flesch-Kincaid Grade Level (FKGL), while information quality was analyzed by five physiotherapists based on the guidelines. Responses were graded using a 4-point system from “excellent response requiring no explanation” to “unsatisfactory requiring significant explanation.” Statistical analyses were performed on SPSS. Results: Overall, all three AI chatbots responded to questions with similar quality, with Gemini 2.0 providing a statistically higher quality response to question 4 (p < 0.05). In terms of readability of the answers, DeepSeek was found to have better readability on Q5 (12.01), Q8 (9.24), Q9 (13.1) and Q10 (8.73) compared to ChatGPT (Q5:13.9, Q8:11.92, Q9:17.15, Q10:9.88) and Gemini (Q5:18.22, Q8:15.47, Q9:17.42, Q10:9.38). Gemini was observed to produce more complex and academic level answers on more questions (Q4, Q5, Q8). Conclusions: ChatGPT, Gemini, and DeepSeek provided evidence-based answers to frequently asked patient questions about COPD. DeepSeek showed better readability performance for many questions. AI chatbots may serve as a valuable clinical tool for COPD patient education and disease management in the future.
YÖKSİS Kayıtları
Evaluation of AI Chatbots for Patient Education and Information on Chronic Obstructive Pulmonary Disease
Heart & Lung · 2026 SCI-Expanded
Doç. Dr. EMİNE CİHAN →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 2 kaydı bulundu.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 2 kaydı bulundu.
Balance performance in patients with heart failure
2020 ISSN: 0147-9563 SCI-Expanded Q3
Doç. Dr. İSMAİL ÖZSOY →
Effects of high intensity interval-based inspiratory muscle training in patients with heart failure: A single-blind randomized controlled trial
2023 ISSN: 0147-9563 SCI-Expanded Q3
Doç. Dr. İSMAİL ÖZSOY →
Makale Bilgileri
Dergi
Heart and Lung
Toplam Atıf
10 atıf
· Scopus
ISSN01479563
Yayın TarihiOcak 2026
Cilt / Sayfa75 · 21-25
Scopus ID2-s2.0-105015490207
Kurumlar
Selçuk Üniversitesi
Selçuklu Turkey
University of Health Sciences
Istanbul Turkey
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 10.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
Heart and Lung
Q2
SJR Skoru0,794
H-Index86
YayıncıElsevier Inc.
ÜlkeUnited States
Cardiology and Cardiovascular Medicine (Q2)
Critical Care and Intensive Care Medicine (Q2)
Pulmonary and Respiratory Medicine (Q2)
Metrikler
10
Atıf